Saitama, Japan

Tatsuro Tago

This inventor holds 1 USPTO granted patent. Top assignee: A&d Company, Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuro Tago. Retrieved from https://idiyas.com/inventor/tatsuro-tago

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tatsuro Tago

Introduction

Tatsuro Tago is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medical devices, particularly with his work on the sphygmomanometer.

Latest Patents

Tatsuro Tago holds one patent for the design and functionality of a sphygmomanometer body. This invention plays a crucial role in the accurate measurement of blood pressure, enhancing the reliability of medical assessments.

Career Highlights

Tatsuro Tago is currently employed at A&D Company, Limited, where he continues to innovate in the medical technology sector. His work has been instrumental in advancing the capabilities of medical devices.

Collaborations

Tatsuro has collaborated with esteemed colleagues such as Yasuhiko Shinozaki and Toshiaki Machitani. Their combined expertise has contributed to the development of innovative solutions in the medical field.

Conclusion

Tatsuro Tago's contributions to medical technology, particularly through his patent for the sphygmomanometer body, highlight his role as an influential inventor. His ongoing work at A&D Company, Limited, along with his collaborations, continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…